CJC-1295 with DAC is a longer-acting GHRH analogue designed to extend growth-hormone release signaling. It is commonly studied for sustained GH and IGF-1 pathway activity, recovery, and body-composition models.
Tried Retatrutide after reading about the triple-agonist mechanism. Interesting compound. Results in our lab have been consistent so far.

